STOCK TITAN
  1. Home
  2. AMYT

Amryt Pharma Plc (AMYT) Stock Price, News & Analysis

AMYT NASDAQ

Company Description

Amryt Pharma Plc (NASDAQ: AMYT) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for AMYT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
63.7M
Shares outstanding

Latest News

View All
—

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

acquisition
+0.21%

High Court of Justice of England and Wales Sanctions Scheme of Arrangement

+0.21%

Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici

acquisition
+0.07%

AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023

acquisition
+107.29%

Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc

acquisition
-0.69%

Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH

clinical trial

Amryt Pharma Plc has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, clinical trial, earnings. View all AMYT news →

SEC Filings

View All

No SEC filings available for AMYT.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

AMYT Company Profile & Sector Positioning

Amryt Pharma Plc (AMYT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.